The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ZALASTA

10 Milligram Orodispersible Tablet

Krka d.d., Novo mestoEU/1/07/415/42-46

Main Information

Trade NameZALASTA
Active SubstancesOLANZAPINE
Strength10 Milligram
Dosage FormOrodispersible Tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/07/415/42-46

Group Information

ATC CodeN05AH03 olanzapine

Status

Authorised/WithdrawnAuthorised
Licence Issued27/10/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0007-002-038
Interchangeable List DocumentPDF of Interchangeable List
« Back